Drug Trial Radar · NCT00633880
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
Last checked: Nov 20, 2026Latest source record: May 20, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
181
Actual
Start
Jan 2008
Primary completion
Aug 2009
Study completion Sep 2009
Sponsor
- Lead sponsor
- Chelsea TherapeuticsIndustry
- Sponsor type
- Industry
- Collaborators
- Chiltern International Inc.
- First posted
- Mar 12, 2008
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to see whether droxidopa is effective in treating symptoms of neurogenic orthostatic hypotension in patients with Primary Autonomic Failure (Pure Autonomic Failure, Multiple System Atrophy, Parkinson's Disease), Non-diabetic neuropathy, or Beta Hydroxylase deficiency.
Conditions
- Symptomatic Neurogenic Orthostatic Hypotension (NOH)
- Non-diabetic Neuropathy
- Primary Autonomic Failure
- Dopamine Beta Hydroxylase Deficiency
Interventions
PlaceboDrug
100 mg, oral, three times per day 200 mg, oral, three times per day 300 mg, oral, three times per day 400 mg, oral, three times per day 500 mg, oral, three times per day 600 mg, oral, three times per day
DroxidopaDrug
100 mg, oral, three times per day 200 mg, oral, three times per day 300 mg, oral, three times per day 400 mg, oral, three times per day 500 mg, oral, three times per day 600 mg, oral, three times per day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in Dizziness/ Lightheadedness/ Feeling Faint/ or Feeling Like You Might Blackout (OHSA Item 1)Time frame: 14 days
Locations
54 sites in 4 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Dedicated Clinical Research
Litchfield Park, Arizona
Xenoscience Inc.
Phoenix, Arizona
Sun Health Research Institute
Sun City, Arizona
The Parkinson's and Movement Disorders Institute
Fountain Valley, California
Pacific Neuroscience Medical Group
Oxnard, California
The Parkinson's Institute
Sunnyvale, California
Electrophysiology Associates
Colorado Springs, Colorado
Parkinson's Disease & Movment Disorder Center
Boca Raton, Florida
Southeastern Integrated Medical
Gainesville, Florida
Mayo Jacksonville Florida Department of Neurology
Jacksonville, Florida
University of Miami
Miami, Florida
University of South Florida
Tampa, Florida
Medical Associates of North Georgia
Canton, Georgia
Saint Mary of Nazareth Hospital Center
Chicago, Illinois
North Chicago VA Medical Center
North Chicago, Illinois
Indiana Medical Research
Elkhart, Indiana
JWM Neurology
Indianapolis, Indiana
Kansas City Bone and Joint, PA
Overland Park, Kansas
University of Louisville
Louisville, Kentucky
University of Maryland
Baltimore, Maryland
Beth Israel Deaconess Medical Center
Boston, Massachusetts
University of Massachusetts Worcester
Worcester, Massachusetts
Henry Ford Health System
Southfield, Michigan
Mayo Clinic Rochester
Rochester, Minnesota
Washington University Medical Center
St Louis, Missouri
New Jersey Neuroscience Institute
Edison, New Jersey
Kingston Neurological Associates, PC
Kingston, New York
NYU Medical Center
New York, New York
Columbia University
New York, New York
University of Rochester
Rochester, New York
Duke University Medical Center
Durham, North Carolina
Wake Forest University
Winston-Salem, North Carolina
University of Cincinnati
Cincinnati, Ohio
University Hospitals Case Medical Center
Cleveland, Ohio
Cleveland Clinic
Cleveland, Ohio
COR Clinical Research, LLC
Oklahoma City, Oklahoma
The Oregon Clinic
Portland, Oregon
Vanderbilt University
Nashville, Tennessee
Jacinto Medical Group, PA
Baytown, Texas
Showing 40 of 54 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.